DRUG APPROVALS: OCTOBER 2010
OCTOBER 4: KAPVAY (CLONIDINE HYDROCHLORIDE) EXTENDED-RELEASE TABLETS
TREATMENT- ADHD
OCTOBER 5: ARIDOL (MANNITOL) INHALATION POWDER
TREATMENT- BRONCHIAL CHALLENGE TEST
OCTOBER 7: SORILUX (CALCIPOTRIENE) FOAM
TREATMENT- PSORIASIS
OCTOBER 8: ATELVIA (RISEDRONATE SODIUM) DELAYED-RELEASE TABLETS
TREATMENT- OSTEOPOROSIS
OCTOBER 14: GAMUNEX-C (IMMUNE GLOBULIN SUBCUTANEOUS ((HUMAN)) INJECTION)
TREATMENT- PRIMARY IMMUNODEFICIENCY SYNDROME
OCTOBER 16: BROMDAY (BROMFENAC) OPTHALMIC SOLUTION
TREATMENT- POSTOPERATIVE OCULAR INFLAMMATION
OCTOBER 19: PRADAXA (DABIGATRAN ETEXILATE) CAPSULES
TREATMENT- PREVENTION OF THROMBOEMBOLISM IN ATRIAL FIBRILLATION
OCTOBER 21: LO LOESTRIN FE (NORETHINDRONE ACETATE & ETHINYL ESTRADIOL TABLES, ETHINYL TABLETS & FERROUS FUMARATE) TABLETS
TREATMENT- CONTRACEPTION
OCTOBER 28: LATUDA (LURASIDONE) TABLETS
TREATMENT- SCHIZOPHRENIA
OCTOBER 29: TEFLARO (CEFTAROLINE FOSAMIL) INJECTION
TREATMENT- PNEUMONIA, SKIN & STRUCTURE INFECTION
OCTOBER 29: NUEDEXTA (DEXTROMETHROPHAN & QUINIDINE)
TREATMENT- PSEUDOBULBAR AFFECT
